Emerging Targets for Developing T Cell-Mediated Vaccines for Human Immunodeficiency Virus (HIV)-1

Human immunodeficiency virus (HIV)-1 has infected >75 million individuals globally, and, according to the UN, is responsible for ~2.1 million new infections and 1.1 million deaths each year. Currently, there are ~37 million individuals with HIV infection and the epidemic has already resulted in 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijesundara, Danushka K., Ranasinghe, Charani, Grubor-Bauk, Branka, Gowans, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660999/
https://www.ncbi.nlm.nih.gov/pubmed/29118747
http://dx.doi.org/10.3389/fmicb.2017.02091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660999/
https://www.ncbi.nlm.nih.gov/pubmed/29118747
http://dx.doi.org/10.3389/fmicb.2017.02091

Ejemplares similares